Haier Biomedical Accelerates Global Expansion in Pursuit of New Opportunities

Over the past month, Haier Biomedical has been actively engaged in various global events, including participating in Gavi’s Global Vaccine Impact Conference, bringing scenario solutions to the SCO Investment Expo, and attending the CEO Roundtable of the United Nations Global Compact, fulfilling its commitment to develop technological advancements while prioritizing users, and aligning with its vision of “making life better”. Through these events, the company is able to showcase Haier Biomedical’s expertise in intellectual manufacturing and exchange future prospects with global industry experts. Now, following the footsteps of the company’s creators, let’s review the highlights of their efforts in the active expansion of its international presence!

Gavi's Global Vaccine Impact Conference

From June 13 to 15, the Global Alliance for Vaccine Immunization (Gavi) held its Global Vaccine Impact Conference in Madrid, Spain. The conference’s theme, “Raising Generation Immunity”, celebrates GAVI’s achievements in protecting an entire generation of children from potentially deadly infectious diseases since 2000.

The conference brought together world leaders and immunization experts, Mr. Guangsheng Wang, the Vice General Manager and Mr. Enrique Wang, the Africa & UN Director of Haier Biomedical were invited to participate in the conference to assess GAVI’s progress in achieving key goals and developing strategies to address future challenges and opportunities.

Wang Guangsheng, Vice General Manager of Haier Biomedical, delivering a speech at the conference.

At the conference, Mr. Guangsheng Wang, the Vice General Manager of Haier Biomedical, shared the company’s efforts in exploration of solar electrification and solar cooling technology, as well as its pioneering measures to reduce carbon emissions. Currently, Haier Biomedical’s product solutions have expanded to 78 countries and regions along the Belt and Road, among which are solar-powered vaccine refrigerators that have served 45 million school-age children annually, which have helped nearly double immunization rates in low-income countries. The company’s pioneering exploration has been unanimously recognized by leaders and immunization experts of the participating countries.

This Global Vaccine Impact Conference is an important milestone in GAVI’s current strategic period. As a long-term partner of GAVI, Haier Biomedical will continue to work with the organization to help promote equitable and accessible vaccination for a better life.

SCO Investment Fair

On June 15, the Shanghai Cooperation Organization Industry Chain Supply Chain Forum and 2023 SCO International Investment and Trade Fair was held in Qinghai, and Haier Biomedical made an entrance with scenario solutions in the life science field, showcasing the fruitful results of friendly cooperation with SCO countries.

The expo, themed “Gathering at SCO - Better Life”, attracted 330 exhibitors from 34 countries and regions along the Belt and Road. On that day, Kyrgyzstan Deputy Prime Minister Edil Baisalov visited the exhibition and expressed his recognition and appreciation for Haier Biomedical’s product solutions and quality. At SCO, the company leverages its potential in science and technology and contributes to building a better life.

Deputy Prime Minister of Kyrgyzstan visiting Haier Biomedical's booth.

UN Global Compact CEO Roundtable

On June 25, the UN Deputy Secretary-General’s visit to China and the UN Global Compact CEO Roundtable took place in Shanghai. The closed-door CEO Roundtable focused on the theme of “Artificial Intelligence and Technology Innovation for the Sustainable Development Goals: The Role and Actions of Business”, aiming to explore the balance between the tremendous opportunities created by the current technological revolution and the unprecedented new challenges to achieve the UN Sustainable Development Goals by 2030, in which Haier Biomedical has been invited to participate as a member of the United Nations Global Compact.

In her keynote address, Amina J. Mohammed, Deputy Secretary-General of the United Nations, emphasized that, “Like many powerful technologies, AI must be guided with human values, human solidarity, and human wisdom. If we are to overcome the climate crisis and make a decisive breakthrough towards a new, more sustainable, and equitable ‘normal’, we need to harness the power of disruptive technologies like AI.”

Guangsheng Wang, Vice General Manager of Haier Biomedical, delivered a speech at this roundtable as a representative of member organizations, highlighting Haier Biomedical’s pioneering practices in promoting new technologies to contribute to sustainable development goals.

“Haier Biomedical is one of the first enterprises to focus on green energy conservation, involving various fields such as hydrocarbon refrigerant research and development and industrialization and popularization, innovative environmental protection foaming technology, the development of solar direct drive refrigeration technology, water conservation and noise reduction, carbon reduction and emission reduction, and supplier management, and has been awarded the title of national green factory. The company has not only fulfilled Its social responsibility, but also reaped economic benefits.

In promoting the innovation of artificial intelligence technology, Haier Biomedical has taken an innovative path of IoT digital scenario solutions, which encompasses various fields including smart lab, smart biospecimen bank, smart public health, smart blood, and smart hospital. These digital scenario solutions align effectively with the UN’s sustainable development goals.”

It is important to always remember the initial inspiration and practice effective planning for long-term success. Haier Biomedical has always been based on user needs, and is committed to deepening scenario solutions, exchanging experiences gained, discussing the new industry blueprint, and befriending international partners, both new and old. These enable the company to create a win-win ecosystem that promotes life sciences and medical innovations, ultimately improving quality of life.